Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
Two immunotherapy drugs could become the new standard of care for people with non-epithelioid mesothelioma. All forms of malignant mesothelioma…
A vast amount of studies suggest that immunotherapy may represent an effective new treatment approach for malignant mesothelioma. Learn your options here.